Save Time, Save Brain, and Save Family
Deep01 is the first AI company in the world to obtain both US and Taiwan FDA clearances
Midline shift detection and measurement
ICH detection, localization, and notification
AI-powered emergency network for brain trauma and stroke
The team members of Deep01 are from Harvard University, Cambridge University, Carnegie Mellon University, National Taiwan University, National Tsing Hua University, and National Chiao Tung University with profound international work experience and from senior physicians in the US and Taiwan.
David Chou, the founder and CEO of Deep01, graduated from Carnegie Mellon University Computer Science and National Taiwan University Electrical Engineering, and was a research fellow at Harvard University. More: https://www.linkedin.com/in/deep01/
Due to excellent achievement in AI medical field, David is awarded as 2020 Ten Outstanding Young Persons (十大傑出青年) and received by President Tsai at the Presidential Office.
US Plug & Play is an investor in Deep01.
Deep01 won the 2nd place out of 900+ teams in a Beijing, China Startup Contest. Deep01 also won the 1st place in the semi-final competition in Taiwan.
Deep01 was top-picked as the TIEC team for Silicon Valley Plan and TechCrunch SF.
Deep01 won the 2nd place in the Dark Horse Contest, the most famous startup contest in China. Deep01 also won the 1st place in the semi-final in Taiwan.
Taiwan Capital TEN (Tsing Hua Entrepreneur Network) is an investor in Deep01.
Deep01 was top-picked as a Harvard MGH fellow with a full scholarship by the Leap Program.
Deep01 was the first AI startup in the Asia-Pacific region to obtain FDA clearance.
Deep01 won the Taiwan Innovation award.
Deep01 was awarded as 2020 Taiwan Top 10 Startups by the Minister of Science and Technology.